Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 084
Main content starts here.
The breadth of the claim in the example does include more DNA embodiments than allelic mutants. The necessary analysis requires an assessment of the adequacy of the description in the specification as to the means of identification of "biological activity X". If identifying allelic mutants or any other DNA capable of hybridizing to sequence X and which would have the claimed activity would require undue experimentation on the part of the skilled artisan, then enablement is lacking.